HGYN HONG YUAN HOLDING GROUP
Plastic Materials, Synth Resins & Nonvulcan Elastomers · OTC · SEC CIK 1324759 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.1%
TTM net income YoY-101.7%
TTM EPS YoY-466.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin66.2%
Operating margin-16.4%
Net margin-17.9%
FCF margin—
EBITDA margin-15.7%
Returns
ROE—
ROA-21.3%
ROIC (approx.)—
Asset turnover1.19x
Leverage & solvency
Liabilities / assets123.2%
Debt / equity—
Current ratio0.78x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.38x
Accruals ratio-13.3%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $837,753 | $245,572 | — | — | — |
| Cost of revenue | $298,108 | $152,675 | — | — | — |
| Gross profit | $539,645 | $92,897 | — | — | — |
| SG&A expense | $236,116 | $152,343 | $114,954 | $21,289 | $5,255 |
| Operating income | $176,478 | -$96,301 | -$154,476 | -$58,348 | -$46,276 |
| Interest expense | — | -$18 | -$12 | — | — |
| Pretax income | $176,689 | -$96,130 | -$154,464 | — | — |
| Income tax | $12,905 | $307 | — | — | — |
| Net income | $155,329 | -$98,844 | -$154,464 | -$58,348 | -$46,276 |
| EBITDA | $178,092 | -$94,945 | -$153,098 | — | — |
| EPS (basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted avg. shares (diluted) | 74.64M | 74.64M | 74.64M | 74.64M | 74.64M |
| Balance sheet | |||||
| Cash & equivalents | $16,747 | $38,527 | $5,983 | — | — |
| Receivables | $404,048 | $11,376 | — | — | — |
| Inventory | $34,286 | $30,786 | — | — | — |
| Current assets | $580,047 | $129,016 | $17,240 | — | — |
| PP&E, net | $209 | $557 | $1,947 | — | — |
| Intangibles | $9,492 | — | — | — | — |
| Total assets | $611,315 | $222,664 | $19,187 | — | — |
| Current liabilities | $591,669 | $372,342 | $156,670 | $111,524 | $53,176 |
| Total liabilities | $591,669 | $391,466 | $156,670 | $111,524 | $53,176 |
| Shareholders' equity | -$62,738 | -$231,454 | -$137,483 | -$111,524 | -$53,176 |
| Shares outstanding | 74.64M | 74.64M | 74.64M | 74.64M | 74.64M |
| Cash flow statement | |||||
| Operating cash flow | -$28,440 | -$89,582 | -$111,866 | — | — |
| Investing cash flow | -$21,755 | — | — | — | — |
| Financing cash flow | $19,478 | $130,634 | $106,314 | — | — |
| Depreciation & amortization | $1,614 | $1,356 | $1,378 | — | — |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.